SaOS-2 cells were seeded into 96-well plates at 5 × 103 cells per well in 0.1 mL of complete DMEM and left to adhere overnight. learn more The medium was then replaced with DMEM supplemented with 0.5% FCS and 100 IU/mL of penicillin and 100 μg/mL of streptomycin (referred hereon in as vehicle) ± metal ion treatments and incubated for 3 or 13 days at 37 °C in a humidified atmosphere of 95% air and 5% CO2. Vehicle ± treatments were replenished every 3rd and 4th day consecutively for cells cultured for 13 days. At the end of the culture period a CellTiter 96® AQueous Non-Radioactive Cell Proliferation

Assay was performed according to the manufacturer’s instructions (Promega, Southampton, UK). The assay utilises dehydrogenase enzymes found in metabolically active cells to convert 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, Ipilimumab supplier inner salt (MTS) into an aqueous soluble formazan product. The absorbance of the formazan product produced by the

cells was read at 490 nm using a SpectraMax M5e Microplate Reader (Molecular Devices, Sunnyvale, CA). Values were expressed as percentage response relative to vehicle. SaOS-2 cells were seeded into 24-well plates at 15 × 103 cells per well in 1 mL of complete DMEM, left to adhere overnight and then the medium was replaced with vehicle ± metal ion treatments and incubated for 13 days at 37 °C in a humidified atmosphere of 95% air and 5% CO2. The vehicle ± treatments were replenished every 3rd or 4th day. Cells were washed with PBS, lysed in nuclease-free water and frozen at − 80 °C following completion of culture. Cell lysates were obtained after three freeze and thaw cycles. ALP activity was measured using p-nitrophenyl phosphate (pNPP) (Sigma) as the chromogenic ALP substrate in the presence of Mg2+ ions in a buffered solution. The absorbance was read at 405 nm using a SpectraMax M5e Microplate Reader. Values were expressed as percentage response relative to vehicle. DNA content was quantified using Quant-iT™ PicoGreen dsDNA Assay Kit (Invitrogen,

Paisley, UK) according to the manufacturer’s instructions. ALP activity was normalised to DNA content and ALP/DNA was then expressed as percentage response relative to vehicle. Once the SaOS-2 cells had reached confluency the cells were treated with vehicle supplemented with 10-8 M dexamethasone and 50 μg/ml ascorbic acid (referred Montelukast Sodium to as osteogenic medium) ± metal ion treatment. Metal ion treatments in osteogenic medium were changed every 3rd or 4th day. Two days prior to experiment end, 10 μL of 5 mM inorganic phosphate 4.2pH was added to the existing treatments within each well. On day 21 cells were then washed once in PBS, fixed in 100% ethanol, rinsed in PBS and incubated in 40 mM alizarin red (pH 4.2; Sigma) for 1 hour at room temperature. The cells were then washed extensively in 95% ethanol and air-dried. The plates were scanned on a high-resolution flat-bed scanner.